These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17675269)

  • 1. Nonsecretory primary plasma cell leukemia with good response to thalidomide-based treatment.
    Brück P; Mousset S; Bühme A; Hoelzer D; Atta J
    Int J Hematol; 2007 Jul; 86(1):66-8. PubMed ID: 17675269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective treatment of primary plasma cell leukemia with thalidomide and dexamethasone - a case report.
    Wöhrer S; Ackermann J; Baldia C; Seidl S; Raderer M; Simonitsch I; Drach J
    Hematol J; 2004; 5(4):361-3. PubMed ID: 15297854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy with bortezomib, cyclophosphamide and dexamethasone may be effective for plasma cell leukemia.
    Kim SJ; Kim J; Cho Y; Seo BK; Kim BS
    Jpn J Clin Oncol; 2007 May; 37(5):382-4. PubMed ID: 17538191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma cell leukemia induced to complete remission with negative minimal residual disease by qualitative PCR analysis after hyper-CVAD and high-dose melphalan followed by autologous peripheral blood stem cell transplantation].
    Hosono N; Yamauchi T; Nakamura T; Yamashita T; Ueda T
    Gan To Kagaku Ryoho; 2008 Mar; 35(3):533-7. PubMed ID: 18347412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide-associated hepatitis: a case report.
    Fowler R; Imrie K
    Am J Hematol; 2001 Apr; 66(4):300-2. PubMed ID: 11279644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage therapy with lenalidomide and dexamethasone in relapsed primary plasma cell leukemia.
    Musto P; Pietrantuono G; Guariglia R; Villani O; Martorelli MC; D'Auria F; Zonno A; Lerose R
    Leuk Res; 2008 Oct; 32(10):1637-8. PubMed ID: 18433866
    [No Abstract]   [Full Text] [Related]  

  • 7. Sustained ventricular tachycardia in a thalidomide-treated patient with primary plasma-cell leukemia.
    Ballanti S; Mastrodicasa E; Bolli N; Lotti F; Capolsini I; Berchicci L; Merigiola C; Giordano G; Tabilio A
    Nat Clin Pract Oncol; 2007 Dec; 4(12):722-5. PubMed ID: 18037876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma cell leukemia maintaining complete remission by syngeneic stem cell transplantation combined with low-dose thalidomide maintenance therapy.
    Abe M; Yokoyama H; Tohmiya Y; Okitsu Y; Ohguchi H; Kohata K; Yamamoto J; Onishi Y; Ishizawa K; Kameoka J; Harigae H
    Intern Med; 2009; 48(20):1833-5. PubMed ID: 19834277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two cases of nonsecretory multiple myeloma presenting as primary plasma cell leukemia.
    Takahashi T; Kanno S; Itoh H; Yoshimoto M; Tsujisaki M; Fujino M
    Intern Med; 2014; 53(18):2121-5. PubMed ID: 25224200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early relapse after complete remission of primary plasma cell leukaemia manifesting clonal evolution: A case report.
    Nyunt WWT; Abdul Jalil D; Zakariah NA; Abdul Karim N; Mohd Idris MR; Nasuruddin DN; Salwati SHUIB; Alauddin H; Tumian NR; Leong CF; Abdul Wahid SFS
    Malays J Pathol; 2020 Apr; 42(1):143-150. PubMed ID: 32342945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide, dexamethasone, Doxil and Velcade (ThaDD-V) followed by consolidation/maintenance therapy in patients with relapsed-refractory multiple myeloma.
    Offidani M; Corvatta L; Polloni C; Gentili S; Mele A; Rizzi R; Catarini M; Caraffa P; Samori A; Blasi N; Ferranti M; Malerba L; Brunori M; Leoni P
    Ann Hematol; 2011 Dec; 90(12):1449-56. PubMed ID: 21437586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary plasma cell leukemia occuring in the young.
    Raj RS; Najeeb S; Aruna R; Pavithran K; Thomas M
    Indian J Cancer; 2003; 40(3):116-7. PubMed ID: 14716116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of bortezomib, lenalidomide and dexamethasone (VRD) in secondary plasma cell leukaemia.
    Gozzetti A; Musto P; Defina M; D'Auria F; Papini G; Statuto T; D'Arena G; Bocchia M
    Br J Haematol; 2012 May; 157(4):497-8. PubMed ID: 22296516
    [No Abstract]   [Full Text] [Related]  

  • 14. [Plasma cell leukaemia].
    Rodriguez C; Pont JC; Gouin-Thibault I; Andrieu AG; Molina T; Le Tourneau A; Le Garff-Tavernier M; Siguret V; Chaibi P
    Ann Biol Clin (Paris); 2005; 63(5):535-9. PubMed ID: 16230292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial.
    Kim HJ; Yoon SS; Lee DS; Sohn SK; Eom HS; Lee JL; Chung JS; Kim K; Suh C; Won JH; Kim JS; Park JS; Kang HJ; Seong CM; Kim CS; Lee SJ; Lee JH
    Ann Hematol; 2012 Feb; 91(2):249-56. PubMed ID: 21789621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma cell leukemia].
    Ravinet A; Bay JO; Tournilhac O
    Bull Cancer; 2014 Nov; 101(11):1048-58. PubMed ID: 25418598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term complete remission in primary plasma cell leukemia after treatment with VAD chemotherapy and tandem autologous peripheral blood stem cell transplantation].
    Iino M; Nakajima A; Shindo H
    Gan To Kagaku Ryoho; 2008 Dec; 35(13):2441-3. PubMed ID: 19098420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma cell leukemia: a rare condition.
    Jiménez-Zepeda VH; Domínguez VJ
    Ann Hematol; 2006 Apr; 85(4):263-7. PubMed ID: 16416115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plasma cell leukemia. Study of 6 patients].
    Las Heras G; Ribera JM; Abella E; Batlle M; Flores A; Millá F; Feliu E
    Sangre (Barc); 1992 Aug; 37(4):255-8. PubMed ID: 1514138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consolidation therapy with autologous stem cell transplantation in plasma cell leukemia after VAD, high-dose cyclophosphamide and EDAP courses: a report of three cases and a review of the literature.
    Hovenga S; de Wolf JT; Klip H; Vellenga E
    Bone Marrow Transplant; 1997 Nov; 20(10):901-4. PubMed ID: 9404934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.